Global Equine Healthcare Market Overview:
Horses are considered sports animals, companion animals, and working animals and provide employment and financial gain in several developed and developing countries. World equestrian market consists of horse racing and betting, competitive riding and leisure. It supports varied secondary markets of that equine healthcare is major. This market includes equine diagnostic merchandise, supplement merchandise and therapeutic merchandise. The participants attracted by high come on investment (ROI) are resulting in market growth. Also, investment by varied alternative nations in racing is driving the expansion of this market. However, handiness of alternatives to gambling like online betting and therefore the declining population of equine is limiting the expansion of this market.
- The Growing Popularity of Horse Racing in Developed and Developing Regions
- Growing Awareness and Affordability of Equine Healthcare Products
- High Equine Adoption Rate in The Household
- Strict Regulations Associated with Horse Racing and Horse Breeding Activities
- Increase In Research and Development Activities
- Increased Sale of Products
- Lack Of Awareness About the Various Products in The Under-Developed Regions
- Increasing Trend of The Indoor Games Like Gambling Have Affected the Sale
The players are highly fragmented in the market. The growing focus of animal care in the region, rising affordability and awareness of equine healthcare products in countries. Moreover, growing demand for equine insurance in the developed countries will further drive the market. However, legislation on horse racing will hinder the market.
Some of the key players profiled in the report are Merck Animal Health (United States), Boehringer Ingelheim Vetmedica (Germany), Affymetrix (United States), Elanco Animal Heath (United States), Zoetis (Pfizer Animal Health) (United States), Equine Health U.K. (United Kingdom), Nutreco N.V. (Netherlands), Phirbo Animal Health (United States), Bayer (Germany), Cargill (United States), Dechra Pharmaceuticals (United Kingdom), Ceva Sante Animale (France), Evonik Industries (Germany) and Eli Lilly and Company (United States). Analyst at AMA Research see United States Players to retain maximum share of Global Equine Healthcare market by 2026. Considering Market by Therapeutic , the sub-segment i.e. Equine Therapeutics Market will boost the Equine Healthcare market. Considering Market by Distribution Channel, the sub-segment i.e. Veterinary Hospitals and Clinics will boost the Equine Healthcare market. Considering Market by Supplement, the sub-segment i.e. Equine Performance Supplements will boost the Equine Healthcare market. Considering Market by Diagnostic, the sub-segment i.e. Equine Pregnancy will boost the Equine Healthcare market.
In August 2018, Zoetis announced the launch of core EQ Innovator, an equine vaccine against tetanus, rabis, western equine encephalomyelitis and two other horse diseases.
What Can be Explored with the Equine Healthcare Market Study
Gain Market Understanding
Identify Growth Opportunities
Analyze and Measure the Global Equine Healthcare Market by Identifying Investment across various Industry Verticals
Understand the Trends that will drive Future Changes in Equine Healthcare
Understand the Competitive Scenario
- Track Right Markets
- Identify the Right Verticals
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Equine Healthcare market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Equine Healthcare market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Manufacturers of Equine Healthcare, Suppliers and distributors of Equine Healthcare, Governmental and Regulatory bodies and End-Users.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.
Frequently Asked Questions (FAQ):1. What is the growth rate predicted for the Global Equine Healthcare Market?
The Equine Healthcare market is expected to see a CAGR of % during projected year 2020 to 2026.
2. Who are the top performing companies in Equine Healthcare Market?
Top performing companies in the Global Equine Healthcare market are Merck Animal Health (United States), Boehringer Ingelheim Vetmedica (Germany), Affymetrix (United States), Elanco Animal Heath (United States), Zoetis (Pfizer Animal Health) (United States), Equine Health U.K. (United Kingdom), Nutreco N.V. (Netherlands), Phirbo Animal Health (United States), Bayer (Germany), Cargill (United States), Dechra Pharmaceuticals (United Kingdom), Ceva Sante Animale (France), Evonik Industries (Germany) and Eli Lilly and Company (United States), to name a few.
3. What trending factors would impact Equine Healthcare Market growth most?
"Growing Demand for Equine Insurance in The Developed Countries" is seen as one of major influencing trends for Equine Healthcare Market during projected period 2020-2026.